Meningitis and stroke associated with potentially contaminated product

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.) ; United States. Food and Drug Administration.
• Description:
  October 4, 2012, 17:05 ET (5:05 PM ET)
  
  CDCHAN-00327-2012-10-04-UPD-N
  
  The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are coordinating a multi-state investigation of fungal meningitis among patients who received an epidural steroid injection. Several of these patients also suffered strokes that are believed to have resulted from their infection. As of October 4, 2012, five deaths have been reported. Fungal meningitis is not transmitted from person to person. These cases are associated with a potentially contaminated medication. Investigation into the exact source is ongoing; however, interim data show that all infected patients received injection with preservative-free methylprednisolone acetate (80mg/ml) prepared by New England Compounding Center, located in Framingham, MA.
  
  
• Subjects:
  Anti-Inflammatory Agents/adverse Effects Aspergillus Fumigatus Disease Outbreaks Drug Compounding Drug Contamination Injections, Epidural Meningitis, Fungal Methylprednisolone Steroids/adverse Effects Stroke
• Source:
  HAN ; 327
• Series:
  Health Alert Network
• Document Type:
  HAN Health Advisory
• Pages in Document:
  2 unnumbered pages
• Issue:
  327
• Collection(s):
  Health Alert Network (HAN)
• Main Document Checksum:
  urn:sha-512:715f86ad12b0478a2ee9e7258a18023a25624ab2c2e0ec6287a631d16456cab71772eaa652651f794eb79ca5a82f9d2e5d6bf0be069a5e0d18509271f39a3b78
• Download URL:
  https://stacks.cdc.gov/view/cdc/25236/cdc_25236_DS1.pdf
• File Type:
  [PDF - 1.46 MB ]